Source: Pigment Cell Melanoma Research. Unidade: FCF
Subjects: QUIMIOTERAPIA, MELANOMA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBECCA, Vito William et al. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Research, v. 27, n. 3, p. 465-478, 2014Tradução . . Disponível em: https://doi.org/10.1111/pcmr.12227. Acesso em: 23 maio 2024.APA
Rebecca, V. W., Massaro, R. R., Fedorenko, I. V., Sondak, V. K., Anderson, A. R. A., Kim, E., et al. (2014). Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Research, 27( 3), 465-478. doi:10.1111/pcmr.12227NLM
Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson ARA, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KSM. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma [Internet]. Pigment Cell Melanoma Research. 2014 ; 27( 3): 465-478.[citado 2024 maio 23 ] Available from: https://doi.org/10.1111/pcmr.12227Vancouver
Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson ARA, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KSM. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma [Internet]. Pigment Cell Melanoma Research. 2014 ; 27( 3): 465-478.[citado 2024 maio 23 ] Available from: https://doi.org/10.1111/pcmr.12227